Biological therapy increases the health-related quality of life in patients with inflammatory bowel disease in a clinical setting. [electronic resource]
Producer: 20161109Description: 706-11 p. digitalISSN:- 1502-7708
- Adalimumab -- therapeutic use
- Adolescent
- Adult
- Aged
- Anti-Inflammatory Agents -- therapeutic use
- Biological Therapy
- Case-Control Studies
- Female
- Follow-Up Studies
- Health Status Indicators
- Humans
- Inflammatory Bowel Diseases -- drug therapy
- Infliximab -- therapeutic use
- Male
- Middle Aged
- Quality of Life
- Retrospective Studies
- Surveys and Questionnaires
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.